< Back to previous page

Project

Microelectrode arrays (MEAs): generally used equipment to measure the functional activity of electrogenic cells.

MEAs provide a non-invasive and non-terminal method for recording electrical activity of electrogenic cells and tissue slices. During previous years we invested in the generation of cellular and animal models of neurological and cardiac diseases that affect neurogenic cells: inherited retinal diseases, neurodegenerative and neurodevelopmental diseases, epilepsy and heart diseases. MEAs are essential to functionally study these models and to assess responses to new therapies.

Date:1 Dec 2020 →  30 Nov 2022
Keywords:Microelectrode array (MEA), Functional cell characterization, Electrogenic cells, Cardiomyocytes, In vitro and in vivo disease modelling, Neuronal cells
Disciplines:Biomedical signal processing, Cell signalling, Molecular biophysics